Electronic monitoring of symptoms and syndromes associated with cancer: Methods of a randomized controlled trial SAKK 95/06 E-MOSAIC

BMC Palliative Care

Volumn 11, Issue , 2012, Pages

  Blum, David ^a,b   Koeberle, Dieter ^a   Ribi, Karin ^c   Schmitz, Shu Fang Hsu ^d,e   Utiger, Urs ^d   Klingbiel, Dirk ^d   Strasser, Florian ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c IBCSG Coordinating Center   (Switzerland)

^d SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BODY WEIGHT; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; DIETARY INTAKE; EDMONTON SYMPTOM ASSESSMENT SCALE; HUMAN; INFORMATION PROCESSING; INFORMATION SYSTEM; INTERPERSONAL COMMUNICATION; KARNOFSKY PERFORMANCE STATUS; MEDICAL ASSESSMENT; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT COUNSELING; PATIENT MONITORING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOLID TUMOR; SYMPTOM; SYNDROME; TUMOR VOLUME;

EID: 84866487741     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/1472-684X-11-19     Document Type: Review

References (59)

1. Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. Doyle C, Crump M, Pintilie M, Oza AM, J Clin Oncol 2001 19 11230467 1266 1274 11230467
2. The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial. Michael M, Hedley D, Oza A, Feld R, Pintilie M, Goel R, Maroun J, Jolivet J, Fields A, Lee IM, et al. Clin Colorectal Cancer 2002 2 2 93 101 10.3816/CCC.2002.n.015 12453323
3. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. Michael M, Tannock IF, CMAJ 1998 158 9676550 1727 1734 9676550
4. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group. Schiller JH, Adak S, Cella D, DeVore RF, Johnson DH, J Clin Oncol 2001 19 11304763 2114 2122 11304763
5. The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Passik SD, Kirsh KL, Hematol Oncol Clin North Am 2000 14 10949778 877 886 10949778
6. What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer? Gough IR, Dalgleish LI, Cancer 1991 68 1710947 220 225 1710947
7. The use of quality of life data in clinical practice. Morris J, Perez D, McNoe B, Qual Life Res 1998 7 9481154 85 91 9481154
8. Role of health-related quality of life in palliative chemotherapy treatment decisions. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK, J Clin Oncol 2002 20 11844830 1056 1062 11844830
9. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials-does HRQOL evaluation in prostate cancer research inform clinical decision making? Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, DHaese S, Zurlo A, J Clin Oncol 2003 21 12972527 3502 3511 12972527
10. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. Buchanan DR, OMara AM, Kelaghan JW, Minasian LM, J Clin Oncol 2005 23 3 591 598 15659506
11. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, et al. J Clin Oncol 2007 25 34 5374 5380 10.1200/JCO.2007.11.2243 18048818
12. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Fearon KC, Voss AC, Hustead DS, Am J Clin Nutr 2006 83 6 1345 1350 16762946
13. Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records. Velikova G, Wright P, Smith AB, Stark D, Perren T, Brown J, Selby P, J Clin Oncol 2001 19 11283140 2064 2073 11283140
14. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK, JAMA 2002 288 12479768 3027 3034 12479768
15. Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being-a Hoosier Oncology Group Study. Fisch MJ, Titzer ML, Kristeller JL, Shen J, Loehrer PJ, Jung S-H, Passik SD, Einhorn LH, J Clin Oncol 2003 21 12860955 2754 2759 12860955
16. Assessing health-related quality of life in palliative care: comparing patient and physician assessments. Petersen MA, Larsen H, Pedersen L, Sonne N, Groenvold M, Eur J Cancer 2006 42 16624553 1159 1166 16624553
17. Physician-identified factors affecting patient participation in reaching treatment decisions. Shepherd HL, Tattersall MH, Butow PN, J Clin Oncol 2008 26 10 1724 1731 10.1200/JCO.2007.13.5566 18375902
18. Consultation length in general practice: cross sectional study in six European countries. Deveugele M, Derese A, van den Brink-Muinen A, Bensing J, De Maeseneer J, BMJ (Clinical research ed) 2002 325 7362 472 10.1136/bmj.325.7362. 472
19. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, et al. J Clin Oncol 1997 15 9196156 2403 2413 9196156
20. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, Bush N, Karras BT, Lober WB, McCorkle R, J Clin Oncol 2011 29 8 1029 1035 10.1200/JCO.2010.30.3909 21282548
21. Identifying patients in need of a palliative care assessment in the hospital setting: a consensus report from the Center to Advance Palliative Care. Weissman DE, Meier DE, J Palliat Med 2011 14 1 17 23 10.1089/jpm.2010.0347 21133809
22. Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. Abernethy AP, Zafar SY, Uronis H, Wheeler JL, Coan A, Rowe K, Shelby RA, Fowler R, Herndon JE 2nd, J Pain Symptom Manage 2010 40 4 545 558 10.1016/j.jpainsymman.2010.01.017 20579839
23. Patients perception of the usefulness of a question prompt sheet for advanced cancer patients when deciding the initial treatment: a randomized, controlled trial. Shirai Y, Fujimori M, Ogawa A, Yamada Y, Nishiwaki Y, Ohtsu A, Uchitomi Y, Psychooncology 2012 21 7 706 713 10.1002/pon.1955 21425387
24. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Velikova G, Brown JM, Smith AB, Selby PJ, Br J Cancer 2002 86 11857011 51 59 11857011
25. Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Stromgren AS, Goldschmidt D, Groenvold M, Petersen MA, Jensen PT, Pedersen L, Hoermann L, Helleberg C, Sjogren P, Cancer 2002 94 11900236 512 520 11900236
26. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K, J Palliat Care 1991 7 1714502 6 9 1714502
27. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E, J Palliat Med 2006 9 16629559 296 303 16629559
28. Symptom prevalence in patients with incurable cancer: a systematic review. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A, J Pain Symptom Manag 2007 34 1 94 104 10.1016/j.jpainsymman.2006.10.015
29. Design and analysis of group-randomized trials: a review of recent methodological developments. Murray DM, Varnell SP, Blitstein JL, Am J Public Health 2004 94 3 423 432 10.2105/AJPH.94.3.423 14998806
30. Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. Fayers PM, Qual Life Res 2008 17 10 1315 1321 10.1007/s11136-008-9391-9 18821031
31. The Mini-Cog as a screen for dementia: validation in a population-based sample. Borson S, Scanlan JM, Chen P, Ganguli M, J Am Geriatr Soc 2003 51 10 1451 1454 10.1046/j.1532-5415.2003.51465.x 14511167
32. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, J Natl Cancer Inst 1993 85 8433390 365 376 8433390
33. Can 40seconds of compassion reduce patient anxiety? Fogarty LA, Curbow BA, Wingard JR, McDonnell K, Somerfield MR, J Clin Oncol 1999 17 10458256 371 379 10458256
34. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Hurny C, Bernhard J, Bacchi M, van Wegberg B, Tomamichel M, Spek U, Coates A, Castiglione M, Goldhirsch A, Senn HJ, Support Care Cancer 1993 1 8193882 200 208 8193882
35. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K, J Palliat Care 1991 7 2 6 9 1714502
36. Clinical relevance of single item quality of life indicators in cancer clinical trials. Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam CM, Br J Cancer 2001 84 11336464 1156 1165 11336464
37. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. Bernhard J, Hurny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn HJ, Rudenstam CM, Ann Oncol 1997 8 9358933 825 835 9358933
38. Patients estimation of overall treatment burden: why not ask the obvious? Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS, J Clin Oncol 2002 20 1 65 72 10.1200/JCO.20.1.65 11773155
39. Do patients want to participate in medical decision making? Strull WM, Lo B, Charles G, JAMA 1984 252 6502860 2990 2994 6502860
40. Statistical considerations in the design and analysis of community intervention trials. Donner A, Klar N, J Clin Epidemiol 1996 49 4 435 439 10.1016/0895-4356(95)00511-0 8621994
41. Sample size re-estimation in cluster randomization trials. Lake S, Kammann E, Klar N, Betensky R, Stat Med 2002 21 10 1337 1350 10.1002/sim.1121 12185888
42. From the help desk: Its all about the sampling. Allen McDowell JP, Stata J 2002 2 Number 2 190 201
43. Michael Friendly, SAS Macro Programs: fpower http://www.math.yorku.ca/ SCS/sasmac/fpower.html
44. Feasibility and compliance of automated measurement of quality of life in oncology practice. Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, et al. J Clin Oncol 2003 21 12525532 374 382 12525532
45. Breast cancer patient perception of the helpfulness of a prompt sheet versus a general information sheet during outpatient consultation: a randomized, controlled trial. Bruera E, Sweeney C, Willey J, Palmer JL, Tolley S, Rosales M, Ripamonti C, J Pain Symptom Manage 2003 25 12727038 412 419 12727038
46. Cancer patients perception of the quality of communication before and after the implementation of a communication strategy in a regional cancer center in India. Nayak S, Pradhan JPB, Reddy S, Palmer JL, Zhang T, Bruera E, J Clin Oncol 2005 23 16034053 4771 4775 16034053
47. Quality of life assessment in daily clinical oncology practice: a feasibility study. Detmar SB, Aaronson NK, Eur J Cancer 1998 34 9849476 1181 1186 9849476
48. Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients need for symptom management support: a randomized clinical trial. Ruland CM, Holte HH, Roislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaloy SO, Hasund L, Ellison MC, J Am Med Inform Assoc 2010 17 4 403 410 10.1136/jamia.2010.005660 20595307
49. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, OFallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL, J Clin Oncol 1998 16 9817289 3662 3673 9817289
50. Improving communication with cancer patients. Maguire P, Eur J Cancer 1999 35 10711246 2058 2065 10711246
51. Meta-analysis of correlates of provider behavior in medical encounters. Hall JA, Roter DL, Katz NR, Med Care 1988 26 7 657 675 10.1097/00005650- 198807000-00002 3292851
52. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. McPherson CJ, Higginson IJ, Hearn J, J Public Health Med 2001 23 11585196 227 234 11585196
53. The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer: A randomized, controlled trial. Bruera E, Pituskin E, Calder K, Neumann CM, Hanson J, Cancer 1999 86 10590386 2420 2425 10590386
54. The art of oncology: when the tumor is not the target. Tell it like it is. Smith TJ, J Clin Oncol 2000 18 19 3441 3445 11013287
55. Effective physician-patient communication and health outcomes: a review. Stewart MA, CMAJ 1995 152 7728691 1423 1433 7728691
56. Doctor-patient interactions in oncology. Ford S, Fallowfield L, Lewis S, Soc Sci Med 1996 42 8771634 1511 1519 8771634
57. SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP, Oncologist 2000 5 10964998 302 311 10964998
58. Patient preferences versus physician perceptions of treatment decisions in cancer care. Bruera E, Sweeney C, Calder K, Palmer L, Benisch-Tolley S, J Clin Oncol 2001 19 11387361 2883 2885 11387361
59. International Association for Hospice and Palliative Care (IAHPC) List of Essential Practices in Palliative Care. De Lima L, Bennett MI, Murray SA, Hudson P, Doyle D, Bruera E, Granda-Cameron C, Strasser F, Downing J, Wenk R, J Pain Palliat Care Pharmacother 2012 26 2 118 122 10.3109/15360288.2012.680010 22764847